SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-16-163500
Filing Date
2016-12-22
Accepted
2016-12-22 16:50:09
Documents
7
Period of Report
2016-12-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a16-23618_18k.htm 8-K 61758
2 EX-2.1 a16-23618_1ex2d1.htm EX-2.1 670820
3 EX-10.1 a16-23618_1ex10d1.htm EX-10.1 112143
4 EX-10.2 a16-23618_1ex10d2.htm EX-10.2 111576
5 EX-10.3 a16-23618_1ex10d3.htm EX-10.3 32575
6 EX-10.4 a16-23618_1ex10d4.htm EX-10.4 32792
7 EX-99.1 a16-23618_1ex99d1.htm EX-99.1 19412
  Complete submission text file 0001104659-16-163500.txt   1042552
Mailing Address 14 WALL ST. SUITE 3D NEW YORK NY 10005
Business Address 14 WALL ST. SUITE 3D NEW YORK NY 10005 212-269-2834
Dipexium Pharmaceuticals, Inc. (Filer) CIK: 0001497504 (see all company filings)

IRS No.: 271707962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36351 | Film No.: 162067113
SIC: 2834 Pharmaceutical Preparations